Glaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for the Wall Street ...

GSK plc announced the acquisition of ordinary shares by several key executives under the Company’s Share Reward Plan. This transaction, conducted on the London Stock Exchange, involved the purchase of ...

Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...

UK-based big pharma GlaxoSmithKline (GSK) has released its Q2 2025 results, which highlight the varying successes of its ...

GSK will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology and inflammation.

The gross profit margin for GLAXOSMITHKLINE PLC is currently very high, coming in at 70.72%. Regardless of GSK's high profit margin, it has managed to decrease from the same period last year.

A month has gone by since the last earnings report for GSK (GSK). Shares have added about 3.2% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up ...

In a report released today, Justin Smith from Bernstein maintained a Buy rating on GlaxoSmithKline, with a price target of £21.70. The company’s shares closed today at p1,373.00. Take advantage of ...

GlaxoSmithKline GSK announced an agreement to acquire joint development and commercialization rights to iTeos Therapeutics’ ITOS early-stage cancer candidate, EOS-448, an anti-TIGIT monoclonal ...

Avandia: GlaxoSmithKline Cover-Up Turns Off Doctors GlaxoSmithKline withheld studies that made their drug Avandia, look unsafe. By ABC News July 13, 2010, 11:24 AM ...

It's all in preparation for GlaxoSmithKline's (NYSE: GSK) grand opening Dec. 13 of its GSK Global Vaccines U.S. R&D Center, its third and final global vaccine hub outside of Belgium and Italy.